Storyline
RFK Jr. mRNA vaccine funding cuts
One page that accretes the verified record as the story develops. Every fact keeps its date and its sources.
368 DAYS
32 FACTS
16 EVENTS
2 SOURCES
FIRST ENTRY AUG 06
AUG 08 · Day 368
mRNA flu shot mFlusiva effectiveness and Long Island access concerns
The FDA approved Moderna's mFlusiva for people ages 50 and older.
Only 56% of Americans believe the COVID vaccine is safe, according to a KFF survey conducted last year.
A study of more than 40,000 people ages 50 to 64 found mFlusiva is 26.6% more effective than a regular-dose traditional flu vaccine in preventing symptoms.
AUG 03 · Day 363
RFK Jr. pushes measles vaccine and criticizes Fauci's COVID-19 handling
Kennedy said he never questioned the efficacy of the MMR vaccine.
The Trump administration announced plans to end gain-of-function research on Tuesday, July 28.
In his diary, Fauci called Trump "out of control" and lamented his own personal fame.
OCT 07 · Day 63
COVID-19 vaccine cost and access after RFK Jr. policy changes
AUG 24 · Day 19
RFK Jr. cancels cancer vaccine work
AUG 22 · Day 17
RFK Jr. warns doctors of liability for straying from CDC vaccine guidance
AUG 22 · Day 17
Risks of Trump's turn against mRNA vaccines
AUG 22 · Day 17
Obstacles anticipated for fall Covid vaccination campaign
AUG 21 · Day 16
Clashing medical advice on COVID-19 shots for children
AUG 19 · Day 14
Pediatrician group recommends COVID vaccine for young children, defying RFK Jr.
AUG 15 · Day 10
Commentary on cancelling mRNA studies
AUG 14 · Day 9
RFK Jr.'s health policies gain traction in states despite lukewarm Congress
AUG 13 · Day 8
RFK Jr supports mRNA research but not for vaccines
AUG 12 · Day 7
RFK Jr. cuts $500M in mRNA vaccine funding
AUG 11 · Day 6
NIH director says mRNA vaccine contracts canceled due to public distrust
AUG 10 · Day 5
RFK Jr. vaccine policy changes raise concerns
AUG 06 · Day 1